4.8 Article

Geographical variability and environmental risk factors in inflammatory bowel disease

Journal

GUT
Volume 62, Issue 4, Pages 630-649

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/gutjnl-2012-303661

Keywords

-

Funding

  1. Ferring
  2. Janssen Hong Kong
  3. Bingham chair in gastroenterology
  4. Abbott Canada
  5. Axcan Pharma
  6. Aptalis
  7. Abbott
  8. MSD Hungary
  9. Abbott Labs
  10. UCB
  11. Janssen Biotech
  12. Shire
  13. Bristol-Myers Squibb
  14. GlaxoSmithKline
  15. Amgen
  16. Pfizer
  17. Braintree
  18. Millenium-Takeda
  19. MSD
  20. Centocor
  21. Abbott Laboratories
  22. Biogen Idec Inc
  23. Boehringer-Ingelheim
  24. Bristol Meyers Squibb
  25. Cellerix SL
  26. Chemocentryx, Inc
  27. Cosmo Technologies, Ltd
  28. Elan Pharmaceuticals, Inc
  29. Genentech
  30. Giuliani Spa
  31. Given Imaging
  32. Glaxo Smith Kline
  33. Immune Pharmaceuticals Ltd
  34. Merck Co, Inc
  35. Millenium Pharmaceuticals Inc
  36. Neovacs SA
  37. Ocerra Therapeutics, Inc
  38. Pfizer Inc
  39. Prometheus
  40. Sanofi
  41. Schering Plough Corp
  42. Shire Pharmaceuticals
  43. Synta Pharmaceutical Corp
  44. Takeda
  45. Teva Pharmaceuticals
  46. Petah Tikva
  47. Therakos
  48. TXcell
  49. UCB Pharma
  50. Wyeth Pharmaceuticals

Ask authors/readers for more resources

The changing epidemiology of inflammatory bowel disease (IBD) across time and geography suggests that environmental factors play a major role in modifying disease expression. Disease emergence in developing nations suggests that epidemiological evolution is related to westernisation of lifestyle and industrialisation. The strongest environmental associations identified are cigarette smoking and appendectomy, although neither alone explains the variation in incidence of IBD worldwide. Urbanisation of societies, associated with changes in diet, antibiotic use, hygiene status, microbial exposures and pollution have been implicated as potential environmental risk factors for IBD. Changes in socioeconomic status might occur differently in different geographical areas and populations and, consequently, it is important to consider the heterogeneity of risk factors applicable to the individual patient. Environmental risk factors of individual, familial, community-based, country-based and regionally based origin may all contribute to the pathogenesis of IBD. The geographical variation of IBD provides clues for researchers to investigate possible environmental aetiological factors. The present review aims to provide an update of the literature exploring geographical variability in IBD and to explore the environmental risk factors that may account for this variability.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available